Results 91 to 100 of about 57,162 (316)

Clinicopathological study of new onset pancytopenia: An experience of largest study from a tertiary care center of western India

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2021
Background: Pancytopenia is characterized by decreased hemoglobin (adult males
Ganesh Pendkur, Paresh Singhal, Venkatesan Somasundaram, S K Raghavendra, Sanjeevan Sharma   +4 more
doaj   +1 more source

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C [PDF]

, 2016
Telaprevir and Boceprevir are the first direct acting antivirals approved for chronic hepatitis C in combination with peg-interferon alfa and ribavirin.
Broquetas, Teresa, Calleja Panero, José Luis, Campillo, Ana, Carrion, José A., Forns, Xavier, Lens Garcia, Sabela, Londoño Hurtado, María Carlota, Mariño, Zoe, Perello, Chrostoe, Revilla, Juan de la, Sánchez Tapias, José M. (José María), Urbano Ispizua, Álvaro   +11 more
core   +1 more source

A case of idiosyncratic drug‐induced agranulocytosis because of sulbactam/ampicillin

Journal of General and Family Medicine, EarlyView.
We report a case of agranulocytosis caused by sulbactam/ampicillin. During antimicrobial therapy, close monitoring of total white blood cell counts is essential. Abstract Idiosyncratic drug‐induced agranulocytosis is a rare but life‐threatening condition that requires immediate medical intervention.
Kazuya Toda, Kaku Kuroda, Moe Kuroda, Kota Kawai, Yukihiro Sato   +4 more
wiley   +1 more source

Fever with pancytopenia: unusual presentation of extrapulmonary tuberculosis: a case report

Journal of Medical Case Reports, 2018
BackgroundTuberculosis is a major health problem in the developing world. Diagnosis of extrapulmonary tuberculosis is delayed because the presentation is nonspecific.
Chamara Dalugama, I. Gawarammana
semanticscholar   +1 more source

To Evaluate the Role of Bone Marrow Aspiration and Bone Marrow Biopsy in Pancytopenia [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: Pancytopenia is not a disease entity but a triad of findings that may result from various disease processes, primarily or secondarily involving the bone marrow.
Melina Desalphine, Permeet Kaur Bagga, Parmod Kumar Gupta, Amarjit Singh Kataria   +3 more
doaj   +1 more source

A rare and threatening complication in a cirrhotic patient [PDF]

, 2018
info:eu-repo/semantics ...
Anapaz, V, Branco, J, Reis, J, Santos, L
core   +1 more source

A Case of Thyrotoxicosis with Pancytopenia.

Endocrine Journal, 2001
We report a 49-year-old man with primary hyperthyroidism who presented with pancytopenia. The patient presented with leg edema, sinus tachycardia, cardiomegaly, and pleural effusions, all from congestive heart failure. Laboratory data showed pancytopenia and primary hyperthyroidism; echocardiogram showed diffuse hyperkinesis of the left ventricular ...
Hideji Tanaka, Nobuo Fukuda, Takeshi Soeki, Hisanori Shinohara, Yoshiyuki Tamura, Noriyasu Kondo, Kanji Bando   +6 more
openaire   +4 more sources

Unexplained Pancytopenia in a Patient with 5q35.2-q35.3 Microduplication Encompassing NSD1: A Case Report

International Journal of Hematology-Oncology and Stem Cell Research, 2018
The 5q35.2-q35.3 duplication phenotype is characterized by growth delay, microcephaly, mental retardation and delayed bone aging. However, there has been no reports on the occurrence of pancytopenia as a consequence of 5q35.2-q35.3 duplication. A 42-year-
Sungwoo Park, Gyeong-Won Lee, Eun-Ha Koh, Hyun-Young Kim   +3 more
doaj   +1 more source

Pembrolizumab-Induced Pancytopenia: A Case Report.

The Permanente Journal, 2017
INTRODUCTION Programmed death receptor-1 blockade with pembrolizumab is approved by the US Food and Drug Administration to treat patients with metastatic melanoma. Activating T cells to fight cancer may cause immune-mediated adverse events. Pembrolizumab-
D. Atwal, K. Joshi, Rahul Ravilla, Fade Mahmoud   +3 more
semanticscholar   +1 more source

Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor‐1 Receptor (CSF1R)‐Related Disorder

Movement Disorders, EarlyView.
Abstract Background Colony stimulating factor‐1 receptor (CSF1R)‐related disorder (CSF1R‐RD) is an autosomal dominant, rapidly progressive, demyelinating disease leading to death usually within a few years. Because of the central role of CSF1R in microglia functions, allogeneic hematopoietic stem cell transplantation (HSCT) has been suggested as a ...
Hemmo A.F. Yska, Marianne Golse, Shanice Beerepoot, Stefanie Hayer, Caroline Bergner, Anderson Rodrigues Brandao de Paiva, Cecilia Marelli, Natalia Julia Palacios, Yudy Llamas Osorio, Camille Huiban, Georg Franke, Friederike Wortmann, Udo Holtick, Xavier Ayrignac, Marjo S. van der Knaap, Ludger Schöls, Vincent Perlbarg, Damien Galanaud, Moniek A. de Witte, Nicole I. Wolf, Stéphanie Nguyen, Fanny Mochel, the International CSF1R‐RD Working Group, Wolfgang Köhler, Angeles Garcia‐Cazorla, Laetitia Souchet, Boris Chaumette, Bernardo Blanco, Magali Barbier, Bruno Stankoff, Anne‐Laure Dubessy, Florence Robert‐Varvat, Audrey Riou, Sacha Weber, Benjamin Bender, Nathalie Fegueux, Patrice Ceballos, Nicolas Menjot de Champfleur, Sylvain Lehmann, Clarisse Cara‐Dallière, Pierre Labauge, Caroline Lindemans, Fernando Freua, Livia Mariano, Leandro Tavares Lucato, Gustavo Bruniera Peres Fernandes, Claudio M. de Gusmão, José Ulysses Amigo Filho, Fernando Kok, Laia Turon, Isabel Badell, Iván López Torija, Marta Gomez   +52 more
wiley   +1 more source